| Literature DB >> 35838971 |
Keiko Iwata1,2,3, Min-Jue Xie4,5,6, Paul C Guest7, Takaharu Hirai8, Hideo Matsuzazki4,5,6.
Abstract
Inflammatory diseases caused by infectious agents such as the SARS-CoV-2 virus can lead to impaired reductive-oxidative (REDOX) balance and disrupted mitochondrial function. Peripheral blood mononuclear cells (PBMCs) provide a useful model for studying the effects of inflammatory diseases on mitochondrial function but can be limited by the need to store these cells by cryopreservation prior to assay. Here, we describe a method for improving and determining PBMC viability with normalization of values to number of living cells. The approach can be applied not only to PBMC samples derived from patients with diseases marked by an altered inflammatory response such as viral infections.Entities:
Keywords: COVID-19; Cryopreservation; Inflammatory disease; Mitochondrial respiration; PBMCs; SARS-CoV-2
Mesh:
Year: 2022 PMID: 35838971 DOI: 10.1007/978-1-0716-2395-4_24
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745